✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Bitopertin is an investigational drug.
There have been 11 clinical trials for Bitopertin. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2010.
The most common disease conditions in clinical trials are Schizophrenia, Thalassemia, and Compulsive Behavior. The leading clinical trial sponsors are Hoffmann-La Roche, Karolinska Institutet, and Niuvanniemi Hospital.
Recent Clinical Trials for Bitopertin
|Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP||Disc Medicine, Inc||Phase 2|
|A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia||Hoffmann-La Roche||Phase 2|
|A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.||Hoffmann-La Roche||Phase 1|